9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, ElSayed, Nuha A., McCoy, Rozalina G., Aleppo, Grazia, Bajaj, Mandeep, Balapattabi, Kirthikaa, Beverly, Elizabeth A., Briggs Early, Kathaleen +19 more·2025·Diabetes Care
DOI 10.2337/dc25-s009

Cites (229)

Items 201–241 of 241

  1. Sodium-glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: meta-analysis of randomized controlled trials
    Rao, Lunwen, Ren, Chenhong, Luo, Shan, Huang, Chenghu, Li, Xuefeng · 2021 · Acta Diabetologica
  2. Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care
    Mehta, Roopa, Goldenberg, Ronald, Katselnik, Daniel, Kuritzky, Louis · 2021 · Annals of Medicine
  3. Meta‐analysis of insulin aspart versus regular human insulin used in a basal–bolus regimen for the treatment of diabetes mellitus (在基础—餐时糖尿病治疗方案中使用门冬胰岛素与使用常规人胰岛素对照研究的Meta分析)
    Heller, Simon, Bode, Bruce, Kozlovski, Plamen, Svendsen, Anne Louise · 2013 · Journal of Diabetes
  4. Cross‐sectional study into quality of life issues surrounding insulin pump use in type 1 diabetes
    KD Barnard, Timothy Charles Skinner · 2008 · Practical Diabetes
  5. Glucagon prescribing and costs among U.S. Adults with diabetes, 2011–2021
    Herges, Joseph R., Galindo, Rodolfo J., Neumiller, Joshua J., Heien, Herbert C., Umpierrez, Guillermo E., McCoy, Rozalina G. · 2023 · Diabetes Care
  6. Glucagon use by U.S. adults with type 1 and type 2 diabetes
    Kahn, Peter A., Liu, Shuling, McCoy, Rozalina, Gabbay, Robert A., Lipska, Kasia · 2021 · Journal of Diabetes and its Complications
  7. A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin U-100 versus concentrated lispro insulin U-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence
    Gentile, Sandro, Fusco, Alessandra, Colarusso, Sara, Piscopo, Marco, Improta, Maria Rosaria, Corigliano, Marco, Martedi, Emilia, Oliva, Domenica, Santorelli, Antonietta, Simonetti, Rosa et al. · 2018 · Expert Opinion on Drug Safety
  8. Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy
    Kali B. Turrin, Jennifer M. Trujillo · 2019 · Diabetes Therapy
  9. Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series
    Lajthia, Estela, Bucheit, John D., Nadpara, Pramit A., Dixon, Dave L., Caldas, Lauren M., Murchie, Michael, Sisson, Evan M. · 2019 · Pharmacy Practice
  10. Posttransplant diabetes mellitus: recent developments in pharmacological management of hyperglycemia
    Munoz Pena, Juan M, Cusi, Kenneth · 2023 · The Journal of Clinical Endocrinology & Metabolism
  11. Results of a 24-week trial of technosphere insulin versus insulin aspart in type 2 diabetes
    Hoogwerf, Byron J., Pantalone, Kevin M., Basina, Marina, Jones, Marisa C., Grant, Marshall, Kendall, David M. · 2021 · Endocrine Practice
  12. Combination therapy with pioglitazone/exenatide improves beta‐cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A <scp>3‐</scp> year follow‐up of the Qatar study
    Abdul‐Ghani, Muhammad, Migahid, Osama, Megahed, Ayman, DeFronzo, Ralph A., Al‐Ozairi, Ebaa, Jayyousi, Amin · 2020 · Diabetes, Obesity and Metabolism
  13. A targeted approach to phosphoinositide-3-kinase/Akt/mammalian target of rapamycin-induced hyperglycemia
    Cheung, Yee-Ming Melody, McDonnell, Marie, Hamnvik, Ole-Petter Riksfjord · 2022 · Current Problems in Cancer
  14. Effect of metformin (vs. placebo or sulfonylurea) on all-cause and cardiovascular mortality and incident cardiovascular events in patients with diabetes: an umbrella review of systematic reviews with meta-analysis
    Bahardoust, Mansour, Mousavi, Sepideh, Yariali, Mohsen, Haghmoradi, Meisam, Hadaegh, Farzad, Khalili, Davood, Delpisheh, Ali · 2023 · Journal of Diabetes &amp; Metabolic Disorders
  15. Effectiveness of shared decision-making for glycaemic control among type 2 diabetes mellitus adult patients: a systematic review and meta-analysis
    Geta, Edosa Tesfaye, Terefa, Dufera Rikitu, Hailu, Wase Benti, Olani, Wolkite, Merdassa, Emiru, Dessalegn, Markos, Gelchu, Miesa, Diriba, Dereje Chala · 2024 · PLOS ONE
  16. Ten-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
    Rury R. Holman, Sanjoy Ketan Paul, Angelyn Bethel · 2009 · Journal of Vascular Surgery
  17. The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: a systematic review and meta-analysis
    Reyes-Farias, Carlos Ignacio, Reategui-Diaz, Marcelo, Romani-Romani, Franco, Prokop, Larry · 2023 · PLOS ONE
  18. An ambulatory stabilisation program for children with newly diagnosed type 1 diabetes
    Shubha Srinivasan, Maria E. Craig, Linda J. Beeney · 2004 · The Medical Journal of Australia
  19. Efficacy of insulin dosing algorithms for high-fat high-protein mixed meals to control postprandial glycemic excursions in people living with type 1 diabetes: A systematic review and meta-analysis
    Al Balwi, Rana, Al Madani, Wedad, Al Ghamdi, Amal · 2022 · Pediatric Diabetes
  20. Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience
    Bartłomiej Matejko, Aneta Kukułka, Beata Kieć‐Wilk · 2018 · Advances in Medicine
  21. Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis
    Chen, Mao-Bing, Xu, Rui-Jun, Zheng, Qi-Han, Zheng, Xu-Wen, Wang, Hua · 2020 · Medicine
  22. A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life
    Daniela Bruttomesso, Federico Boscari, Giuseppe Lepore, Giulia Noaro, Giacomo Cappon, Angela Girelli, Lutgarda Bozzetto, Andrea Tumminia, Giorgio Grassi, Giovanni Sparacino et al. · 2021 · Diabetes Therapy
  23. All 3 major insulin manufacturers are cutting their prices-here's what the news means for patients with diabetes
    Suran, Melissa · 2023 · JAMA
  24. Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus
    Aronson, Ronnie, Biester, Torben, Leohr, Jennifer, Pollom, Robyn, Linnebjerg, Helle, LaBell, Elizabeth Smith, Zhang, Qianyi, Coutant, David E., Danne, Thomas · 2023 · Diabetes, Obesity and Metabolism
  25. The effect of sodium-glucose cotransporter 2 inhibitors as an adjunct to insulin in patients with type 1 diabetes assessed by continuous glucose monitoring: a systematic review and meta-analysis
    Li, Mengnan, Liu, Zi'ang, Yang, Xifeng, Zhang, Jiaxin, Han, Minmin, Zhang, Yi, Liu, Yunfeng · 2023 · Journal of Diabetes and its Complications
  26. Efficacy and Safety of Once Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)
    Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun, Alan G. Zimmermann, Valeria Pechtner · 2014 · Canadian Journal of Diabetes
  27. Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index
    Yukari Mitsui, Akio Kuroda, Masashi Ishizu, Hiroyasu Mori, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Yuko Akehi, Ken‐ichi Aihara, Itsuro Endo et al. · 2021 · Journal of Diabetes Investigation
  28. Glucagon fill rates and cost among children and adolescents with type 1 diabetes in the United States, 2011–2021
    Benning, Tyler J., Heien, Herbert C., Herges, Joseph R., Creo, Ana L., Al Nofal, Alaa, McCoy, Rozalina G. · 2023 · Diabetes Research and Clinical Practice
  29. The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    all on behalf of Associazione Medici Endocrinologi (AME), Elena Castellano, Roberto Attanasio, Vito Angelo Giagulli, Alberto Boriano, Massimo Terzolo, Enrico Papini, Edoardo Guastamacchia, Salvatore Monti, Alberto Aglialoro et al. · 2018 · Journal of Diabetes & Metabolic Disorders
  30. Optimizing basal insulin dosing
    Lal, Rayhan A., Maahs, David M. · 2019 · The Journal of Pediatrics
  31. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
    JP Frias, Melanie Jane Davies, J Rosenstock · 2022 · Yearbook of pediatric endocrinology
  32. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
    Apostolos Tsapas, Thomas Karagiannis, Ioannis Avgerinos, David Richard Matthews, Eleni Bekiari · 2021 · Annals of Internal Medicine
  33. Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
    Andrea C. Tricco, Huda M. Ashoor, Charlene Soobiah, Brenda R. Hemmelgarn, David Moher, Brian Hutton, Catherine H. Y. Yu, Sumit R. Majumdar, Sharon Elizabeth Straus · 2013 · Systematic Reviews
  34. Mean basal insulin dose is 0.2 U/kg/d at near normal glycaemia for type 1 or 2 diabetes on continuous subcutaneous insulin infusion or once‐nightly basal insulin
    Allen Bennett King · 2020 · Diabetes Obesity and Metabolism
  35. Starting subcutaneous insulin doses in a paediatric population with newly diagnosed type 1 diabetes
    Lisa Lemieux, Susan G. Crawford, Danièle Pacaud · 2010 · Paediatrics & Child Health
  36. A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study
    Martina Parise, Sergio Di Molfetta, Roberta Teresa Graziano, Raffaella Fiorentino, Antonio Cutruzzolà, Agostino Gnasso, Concetta Irace · 2023 · International Journal of Environmental Research and Public Health
  37. Abstract #291: Efficacy and Safety of Liraglutide Addded to Insulin Treatment in Type 1 Diabetes, The Adjunct One Treat-Totarget Randomized Trial
    Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingson · 2016 · Endocrine Practice
  38. Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)
    John M. Lachin, David M. Nathan · 2021
  39. Simplified Meal Announcement versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control
    Goran Petrovski, Judith Campbell, Maheen Pasha · 2023
  40. 379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 Diabetes
    Peter A. Kahn, SHULING LIU, Rozalina G. McCoy, Robert A. Gabbay, Kasia J. Lipska · 2020 · Diabetes
  41. 786-P: Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV
    SAMUEL DAGOGO-JACK, RICHARD E. PRATLEY, DAVID CHERNEY, BERNARD CHARBONNEL, DARREN K. MCGUIRE, FRANCESCO COSENTINO, WEICHUNG J. SHIH, JIE LIU, ROBERT FREDERICH, JAMES P. MANCUSO et al. · 2021 · Diabetes